Purchases and Sales Made in Q4 2021 in Lexaria Bioscience Corp. (LEXX)
This table provides information about the institutional ownership of Lexaria Bioscience Corp. (LEXX) during Q4 2021. The information is specifically focused on institutions that hold shares of Lexaria Bioscience Corp..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 11, 2022
Q4 2021
|
Invenomic Capital Management LP
Boston, MA |
BUY
|
- |
6.69K+ 1.9% |
$25.9K - $46.2K
|
359K
$639K
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
4.13KNew |
$16K - $28.5K
|
4.13K
$7.36K
|
|
Feb 14, 2022
Q4 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
3.29K+ 10.66% |
$12.7K - $22.7K
|
34.1K
$60.7K
|
|
Jan 21, 2022
Q4 2021
|
Edge Wealth Management LLC
|
BUY
|
- |
2.98K+ 852.29% |
$11.5K - $20.6K
|
3.33K
$5.93K
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.2KNew |
$4.66K - $8.31K
|
1.2K
$2.14K
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1K+ 4000.0% |
$3.87K - $6.9K
|
1.03K
$1.82K
|
|
Feb 14, 2022
Q4 2021
|
Aspire Private Capital, LLC
|
BUY
|
- |
400New |
$1.55K - $2.76K
|
400
$712
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-999- 99.9% |
$3.87K - $6.89K
|
1
$1.78
|
|
Jan 14, 2022
Q4 2021
|
Edge Wealth Management LLC
|
SELL
|
- |
-2.98K- 89.5% |
$11.5K - $20.6K
|
350
$623
|
|
Feb 17, 2022
Q4 2021
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-11.9KClosed |
$46.2K - $82.4K
|
0
$0
|